• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Shanda Interactive Entertainment

Shanda Interactive Entertainment

  1. All
  2. 3rd Party
  3. Investing
  1. VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA ; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity

    VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA ; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity

  2. Perfect World Entered Into Agreement to Sell Its Shares in Shanda Games

    Perfect World Entered Into Agreement to Sell Its Shares in Shanda Games

  3. Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers

    Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers

  4. Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NETs1 in the US with Priority Review

    Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NETs1 in the US with Priority Review

  5. Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe

    Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe

  6. New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures

    New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures

  7. Ways to Play China's Online Gaming Sector

    Think big if you're serious about investing in virtual fun and games.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.